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Abstract
Purpose To review the incidence of UTIs, post-operative
fever, and risk factors for post-operative fever in PCNL
patients.
Materials and methods Between 2007 and 2009, con-
secutive PCNL patients were enrolled from 96 centers
participating in the PCNL Global Study. Only data from
patients with pre-operative urine samples and who received
antibiotic prophylaxis were included. Pre-operative bladder
urine culture and post-operative fever ([38.5C) were
assessed. Relationship between various patient and opera-
tive factors and occurrence of post-operative fever was
assessed using logistic regression analyses.
Results Eight hundred and sixty-five (16.2%) patients had
a positive urine culture; Escherichia coli was the most
common micro-organism found in urine of the 350 patients
(6.5%). Of the patients with negative pre-operative urine
cultures, 8.8% developed a fever post-PCNL, in contrast to
18.2% of patients with positive urine cultures. Fever
developed more often among the patients whose urine
cultures consisted of Gram-negative micro-organisms
(19.4–23.8%) versus those with Gram-positive micro-
organisms (9.7–14.5%). Multivariate analysis indicated
that a positive urine culture (odds ratio [OR] = 2.12, CI
[1.69–2.65]), staghorn calculus (OR = 1.59, CI [1.28–
1.96]), pre-operative nephrostomy (OR = 1.61, CI [1.19–
2.17]), lower patient age (OR for each year of 0.99, CI
[0.99–1.00]), and diabetes (OR = 1.38, CI [1.05–1.81]) all
increased the risk of post-operative fever. Limitations
include the use of fever as a predictor of systemic infection.
Conclusions Approximately 10% of PCNL-treated
patients developed fever in the post-operative period
despite receiving antibiotic prophylaxis. Risk of post-
operative fever increased in the presence of a positive urine
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bacterial culture, diabetes, staghorn calculi, and a pre-
operative nephrostomy.
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Introduction
Percutaneous nephrolithotomy (PCNL) is the preferred
method of removing renal calculi, particularly among the
patients with a large or complex stone burden, resulting in
stone free rates exceeding 90% [1, 2]. However, up to
one-third of PCNL patients experience some peri-opera-
tive complications [3], the most common being fever
secondary to a urinary tract infection (UTI), which occurs
in 21–39.8% of the patients [4, 5]. Although the vast
majority of post-PCNL temperature elevations are tran-
sient in nature, between 0.3 and 9.3% of patients can
develop potentially life-threatening sepsis [4, 5]. The
pathogenesis of UTIs after PCNL treatment is thought to
begin with bacterial release from surgical manipulation
and/or fragmentation of calculi or the introduction of
bacteria via the nephrostomy tract [6]. Additionally,
numerous patient characteristics and operative factors
have been reported to augment the risk of infection post-
PCNL, including positive pre-operative urinary culture,
female sex, operative time, use of a nephrostomy tube,
and prior PCNL procedures among others [5–8]. Unfor-
tunately, the associations between any one factor and the
post-PCNL risk of UTIs have been largely inconsistent
across studies.
The European Association of Urology (EAU) guidelines
suggest that all potential PCNL patients with infection
stones, recent history of UTI, or positive urine culture
should receive antibiotic therapy before the stone-remov-
ing procedure and it be continued for least 4 days post-
operatively [9]. Furthermore, antibiotic prophylaxis may
also reduce the risk of post-PCNL infectious complications
among the patients with sterile urine and non-infectious
calculi [10]. However, antibiotic prophylaxis fails to
completely eliminate the risk of infection associated with
the PCNL procedure [5, 7].
The Clinical Research Office of the Endourological
Society (CROES) is responsible for organizing, structuring,
and facilitating a global network for endourological
research [11]. Their first major initiative involved the
development of the PCNL Global Study, a prospective
global database of indications and outcomes of PCNL. The
aims of the current investigation were to review the inci-
dence of UTIs and to assess the risk factors associated with
the occurrence of post-operative fever among the PCNL
patients.
Materials and methods
The organizational details of the CROES PCNL Global
Study have been previously reported including the
operative procedure [12]. Between November 2007 and
December 2009, 5,803 consecutive patients treated over
a 1-year period at each of 96 participating global centers
were included in the PNCL Global Study. Patients eli-
gible for inclusion in the study were all those who were
candidates for PCNL treatment as the primary indication
or following the failure of previous treatment. For the
current analysis, only patients with a pre-operative urine
culture and antibiotic prophylaxis were included.
Bladder urine samples were obtained prior to surgical
procedure at the discretion of the treating physician, and
subsequently tested for the presence of bacterial cultures.
Regardless of the presence of a positive urine culture, all
patients received antibiotic prophylaxis according to indi-
vidual protocols at each center. The presence of a post-
operative fever of C38.5C as a proxy for infection was
assessed according to the established protocols at each
participating center. Institutional review board approval
was obtained if required; otherwise, the lead investigator
was responsible for ensuring the quality of clinical data
collected.
Statistical analysis
The relationship between various patient and operative
factors and the occurrence of post-operative fever was
assessed using univariate and multivariate logistic regres-
sion analyses. Backward selection of variable was per-
formed to optimize the model. The level of significance
was defined as P \ 0.05. All analyses were performed
using SPSS version 16.0.
Results
Characteristics of all 5803 patients included in the Global
PCNL Study, the intra-operative details of the PCNL pro-
cedure, and the post-operative treatment outcomes have
been previously described elsewhere [12]. A total of 5,354
(92.2%) patients with available pre-operative urine samples
and who received antibiotic prophylaxis were included in
the current analysis. Patient characteristics are shown in
Table 1.
Overall, 865 (16.2%) patients assessed were found to
have a positive urine culture. The frequency of the different
micro-organisms found in the pre-operative urine cultures
of PCNL patients is outlined in Table 2. Escherichia coli
was the most common micro-organism found, and the
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frequency of micro-organisms was consistent across the
four continents assessed with the exception of North
America where the incidence of positive cultures was
higher. The frequency of E. Coli was considerably lower in
North America (20.9%) as compared with the other con-
tinents (range 39.4–57.4%). Conversely, the frequency of a
mixed colony sample was notably higher in North America
(19.4%) in comparison with the other continents (range
1.7–10.6%).
Of the 5,313 PCNL patients who had data on both pre-
operative urine culture and post-operative body tempera-
ture, 550 (10.4%) patients had developed a fever. Table 3
provides the proportion of patients experiencing a fever
according to the type of micro-organism found pre-opera-
tively in their urine. Of note, 8.8% of patients with negative
urine cultures prior to treatment developed a fever post-
PCNL, in contrast to 18.2% of patients with positive urine
cultures. Nevertheless, the prevalence of fever among those
with a positive urine culture varied markedly depending on
which micro-organisms were found in their urine cultures,
from a low of 9.7% among those with Staphylococcus spp.
to a high of 23.8% among those with Enterobacter spp.
Table 4 depicts the relationship between various patient
and intra-operative factors and the risk of post-PCNL fever,
as assessed by univariate and multivariate analyses. In
univariate analysis, a longer operation time for each addi-
tional minute, positive pre-operative urine culture, a stag-
horn calculus, residual stones, pre-operative presence of a
nephrostomy, and a diagnosis of diabetes all predicted a
greater likelihood of post-operative fever. In multivariate
analysis, after controlling for all other factors, a positive
urine culture, staghorn calculus, pre-operative presence of
a nephrostomy, lower patient age, and diabetes were all
associated with an increased risk of post-operative fever.
Discussion
Fever secondary to a UTI is one of the most common
sequelae of PCNL, occurring in 21–39.8% of patients [4,
Table 1 Patient characteristics
Parameter Mean (SD)
Age (years) 49.2 (15.6)
Body Mass Index (kg/m2) 26.7 (5.2)
Stone burden (mm2) 375.9 (236.6)
N (%)a
Sex
Male 3,015 (56.4)
Female 2,334 (43.6)
Diabetes 719 (13.5)
ASA score
ASA 1 2,861 (54.1)
ASA 2 1,813 (34.3)
ASA 3 568 (10.7)
ASA 4 49 (0.90)
Pre-operative nephrostomy 421 (8.0)
Staghorn stone 1,357 (27.2)
Positive pre-operative urine cultures 865 (16.2)
a Complete variable sets analyzed
Table 2 Frequency of micro-organisms in positive urine cultures of percutaneous nephrolithotomy patients
Total sample
N (%)
Asia
N (%)
Europe
N (%)
North America
N (%)
South America
N (%)
Prevalence of positive cultures 16.2% (865/5,354) 16.0% (209/1,308) 12.6% (387/3,071) 30.4% (211/695) 20.7% (58/280)
Prevalence of negative cultures 83.8% (4,489/5,354) 84.0% (1,099/1,308) 87.4% (2,685/3,071) 69.6% (483/695) 79.3% (222/280)
Total positive culture 865 (100.0) 209 (100.0) 387 (100.0) 211 (100.0) 58 (100.0)
Isolated micro-organism
Escherichia coli 350 (40.5) 120 (57.4) 153 (39.4) 44 (20.9) 33 (56.9)
Proteus spp. 95 (11.0) 11 (5.3) 50 (13.0) 28 (13.3) 6 (10.4)
Klebsiella spp. 65 (7.5) 25 (12.0) 32 (8.3) 8 (3.8) 0 (0.0)
Others 45 (5.2) 4 (1.9) 22 (5.7) 19 (9.0) 0 (0.0)
Enterococcus spp. 71 (8.2) 10 (4.8) 39 (10.0) 18 (8.5) 4 (6.9)
Staphylococcus spp. 62 (7.2) 11 (5.3) 18 (4.7) 30 (14.2) 3 (5.2)
Enterobacter spp. 21 (2.4) 8 (3.8) 8 (2.1) 4 (1.9) 1 (1.7)
Pseudomonas spp. 69 (8.0) 16 (7.7) 24 (6.2) 19 (9.0) 10 (17.2)
Mixed 87 (10.0) 4 (1.8) 41 (10.6) 41 (19.4) 1 (1.7)
Others include the following micro-organisms: Alcaligenes spp., Serratia spp., Lactobacilli spp., Citrobacter spp., Providencia spp., Aerococcus
spp., Corynebacter spp., Aeromonas spp., Acinetobacter spp., Morganella spp., Candida spp., and Streptococcus spp.
A mixed colony contained a positive culture with more than one organism
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5]. Interestingly, only 10.4% of the sample in the current
study experienced a post-operative fever. A number of
factors may explain the wide variation in the incidence of
post-PCNL fever across studies. First, the temperature cut-
off used to define a fever varies between studies; while a
temperature of [38.5C was used in the current study,
others have used a temperature of [38.0C [8], C38.0C
[5], or did not specify a temperature cut-point [4]. Indeed,
in one study [13], the proportion of PCNL patients who
experienced a post-operative fever of [38.0C and
[38.5C was 28.8 and 16.7%, respectively. Secondly, the
time between PCNL and subsequent temperature assess-
ment may also influence the prevalence of fever reported in
a given study. For example, Draga et al. [5] found that
while 39.8% of patients had developed a fever within 24 h
of PCNL, this rate fell to just 13.0% when assessed beyond
24 h post-operatively.
Despite the fact that all patients in the current study
received antibiotic prophylaxis, 18.2% of those with a
positive pre-operative urine culture and 8.8% of those with
sterile urine culture developed a post-operative fever. A
previous study has indicated that 1 week of ciprofloxacin
prophylaxis prior to PCNL significantly reduced the risk of
urosepsis [10]. Nevertheless, in agreement with prior
studies [5, 7, 8], our findings support the notion that anti-
biotic prophylaxis fails to completely eliminate the risk of
infection associated with the PCNL procedure. Either
bacterial resistance to antibiotic treatment [14] or the
administration of an inappropriate antibiotic for the bac-
terial culture present in the upper urinary tract [5] may
explain this apparent failure.
While 16.2% of patients in our database had a positive
pre-operative bladder urine culture, others have previously
reported rates ranging from 4.1 [8] to 53.6% [5]. Of the
PCNL patients with a positive urine culture in the current
study, E. coli was the most commonly isolated micro-
organism, accounting for 40.5% of positive cultures. This
finding is in agreement with prior studies of UTI patients,
where E. coli was the predominant bacterial pathogen
found in bladder urine [15], but contrast with those of
Mariappan et al. [16] who found a mixed bacterial colony
to be far more common than E. coli alone in the bladder
urine of a small sample of PCNL patients (\20 vs. [60%,
respectively). Interestingly enough, the authors reported
that E. coli represented over 60% of positive cultures of
pelvic urine in the same patients. Our results also illus-
trated significant geographic-dependant variation in the
Table 3 Proportion of patients experiencing post-operative fever
according to urine culture
Fever
N (%)
No fever
N (%)
Total negative culture 394 (8.8) 4,062 (91.2)
Total positive culture 156 (18.2) 701 (82.8)
Isolated micro-organism
Escherichia coli 71 (20.3) 279 (79.7)
Proteus spp. 18 (19.4) 75 (80.6)
Klebsiella spp. 15 (23.1) 50 (76.9)
Others 7 (15.9) 37 (84.1)
Enterococcus spp. 10 (14.5) 59 (85.5)
Staphylococcus spp. 6 (9.7) 56 (90.3)
Enterobacter spp. 5 (23.8) 16 (76.2)
Pseudomonas spp. 14 (20.6) 54 (79.4)
Mixed 10 (11.8) 75 (88.2)
Others include the following micro-organisms: Alcaligenes spp.,
Serratia spp., Lactobacilli spp., Citrobacter spp., Providencia spp.,
Aerococcus spp., Corynebacter spp., Aeromonas spp., Acinetobacter
spp., Morganella spp., Candida spp., and Streptococcus spp.
A mixed colony contained a positive culture with more than one
organism
Table 4 Factors associated with post-operative fever among percutaneous nephrolithotomy patients
Univariate Multivariate
OR 95% CI P value OR 95% CI P value
Female sex 1.12 0.94–1.34 0.193 0.92 0.75–1.12 0.389
Patient age (years) 1.00 0.99–1.00 0.184 0.99 0.99–1.00 0.022
Diabetes 1.28 1.0–1.63 0.046 1.38 1.05–1.81 0.021
Positive urine culture 2.26 1.85–2.77 \0.001 2.12 1.69–2.65 \0.001
Pre-operative nephrostomy 1.77 1.34–2.34 \0.001 1.61 1.19–2.17 0.002
Operation time (mins) 1.00 1.00–1.01 \0.001 1.00 1.00–1.00 0.055
Staghorn calculus 1.88 1.56–2.28 \0.001 1.59 1.28–1.96 \0.001
Residual stone 1.47 1.21–1.78 \0.001 1.16 0.92–1.45 0.203
Post-operative nephrostomy 1.45 1.00–2.09 0.048 1.26 0.85–1.88 0.249
Prednisone treatment 1.71 0.86–3.38 0.125 1.75 0.83–3.69 0.142
With the exception of patient age and operation time, all other variables were coded as dichotomous
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bladder urine cultures of PCNL patients. For example, a
mixed colony accounted for 1.7% of positive cultures
among the patients from South America, but 19.4% among
the patients from North America. Conversely, E. coli was
the only micro-organism in 20.9 and 57.4% positive urine
cultures of North American and Asian PCNL patients,
respectively.
While some have criticized the value of pre-operative
bladder urine culture in predicting post-operative infection
and associated complications [6, 16], our data clearly
illustrate that a positive culture is associated with a twofold
risk of fever in the post-operative period. These findings
are consistent with those of Aghdas and colleagues [8],
who found a higher rate of fever post-PCNL among the
patients with positive versus negative urine culture (50 vs.
33.3%, respectively). Additionally, results of the current
investigation suggest that the risk of post-operative fever
among the patients with a positive urine culture depends on
the specific micro-organisms found in their urine. Specifi-
cally, post-operative fever was reported in 9.7–14.5% of
the patients whose urine cultures consisted of Gram-positive
micro-organisms (Staphylococcus spp. and Enterococcus
spp.) but in 19.4–23.8% of the patients with Gram-negative
micro-organisms (e.g., E. coli, Enterobacter spp., and
others).
In addition to a positive urine culture, the logistic
regression analysis in the current study uncovered a num-
ber of risk factors for post-PCNL fever. First, in agreement
with the established association between staghorn or stru-
vite calculi and risk of UTIs caused by urea-splitting bac-
teria [17], the presence of staghorn calculi was shown to
independently increase the risk of fever by approximately
60%. This finding contrasts with prior studies with rela-
tively small sample sizes which failed to find an association
between staghorn calculi and symptoms of infection post-
PCNL [5, 8]. Diabetic PCNL patients were also at signif-
icantly greater risk of developing a fever in the post-
operative period, not surprisingly given that diabetes pro-
foundly elevates the risk of developing UTIs [18]. In
agreement with at least one prior study [8], the use of a
nephrostomy tract was also associated with a 60%
increased risk of post-operative fever. Although the reason
for this finding is unclear, some authors have suggested that
a nephrostomy tract may simply be used during more
complicated cases, rather than directly affecting the risk of
infection [8]. While it is well established that women are
generally at greater risk of UTIs in comparison with men
[19], we found no relationship between the sex and risk of
fever post-PCNL, a finding corroborated by others [5, 16].
Finally, in agreement with numerous prior efforts [5, 8,
16], once other factors were accounted for in multivariate
analysis, the duration of the operation was not a significant
predictor of post-operative fever risk.
In regard to study limitations, it has been argued that
fever alone cannot be used as an indicator of systemic
infection. Rao et al. [20] reported that while 74% of the
PCNL patients in their study developed post-operative
fever, only 41% had endotoxemia. Others suggest that
transient post-PCNL fever is often caused by a bodily
reaction to the operation and resorption of an hematoma
and does not accurately represent post-PCNL sepsis [5].
Although bladder urine was used to assess the UTIs in the
current study, some argue that bacterial culture of bladder
urine is often a poor indicator of cultures found in upper
urinary tract urine and in renal calculi [16]. Finally, the
details of antibiotic treatment and fever assessment were
not available, and thus, any potential variability in these
factors could not be accounted for in the analysis.
Conclusion
The study showed that approximately 10% of patients
developed fever post-PCNL despite receiving antibiotic
prophylaxis. Predictors of post-operative fever include
positive urine culture, diabetes, the presence of a staghorn
calculus, and the pre-operative use of a nephrostomy tube.
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